Sonnet Biotherapeutics Holdings Stock Technical Analysis

SONN Stock  USD 1.52  0.02  1.33%   
As of the 26th of February, Sonnet Biotherapeutics has the Risk Adjusted Performance of (0.07), variance of 49.85, and Coefficient Of Variation of (963.27). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sonnet Biotherapeutics, as well as the relationship between them.

Sonnet Biotherapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sonnet, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Sonnet
  
Sonnet Biotherapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Sonnet Biotherapeutics Analyst Consensus

Target PriceAdvice# of Analysts
160.0Strong Buy1Odds
Sonnet Biotherapeutics Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Sonnet analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sonnet stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sonnet Biotherapeutics, talking to its executives and customers, or listening to Sonnet conference calls.
Sonnet Analyst Advice Details
Sonnet Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sonnet Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sonnet Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Sonnet Biotherapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sonnet Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Sonnet Biotherapeutics Trend Analysis

Use this graph to draw trend lines for Sonnet Biotherapeutics Holdings. You can use it to identify possible trend reversals for Sonnet Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sonnet Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Sonnet Biotherapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Sonnet Biotherapeutics Holdings applied against its price change over selected period. The best fit line has a slop of   0.01  , which may suggest that Sonnet Biotherapeutics Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 4.52, which is the sum of squared deviations for the predicted Sonnet Biotherapeutics price change compared to its average price change.

About Sonnet Biotherapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sonnet Biotherapeutics Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sonnet Biotherapeutics Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sonnet Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Sonnet Biotherapeutics. By analyzing Sonnet Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sonnet Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sonnet Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Sonnet Biotherapeutics February 26, 2025 Technical Indicators

Most technical analysis of Sonnet help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sonnet from various momentum indicators to cycle indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Sonnet Biotherapeutics February 26, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sonnet stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.45)
Revenue Per Share
0.959
Quarterly Revenue Growth
52.688
Return On Assets
(1.34)
Return On Equity
(2.85)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.